Visalytics
Visalytics
approved EB-2 (NIW)

Pediatrician

Immunology · Israel · 2025-05-28

Processing Time
13 days
Decision Date
2025-05-28
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to utilize advanced genome sequencing, immunoprofiling, and real-world patient data to uncover genetic and immune mechanisms underlying pediatric diseases. The work focuses on developing early diagnostic tools and targeted, individualized therapies for pediatric autoimmune and neurodevelopmental disorders.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the urgent need for accurate diagnosis and treatment of pediatric autoimmune and neurodevelopmental disorders affecting 30% of U.S. children.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds an M.D./Ph.D., has completed all USMLE steps, and has a track record of highly cited research in fetal neurodevelopment.

3 Balance of Factors to Waive Job Offer Met

The U.S. has an urgent need for clinician-researchers capable of translating molecular research into clinical diagnostics and healing.

Why This Petition Was Approved

The petition was approved based on the applicant's dual M.D./Ph.D. credentials and a record of over 100 citations across multiple peer-reviewed journal articles. Evidence included her ECFMG certification and research demonstrating therapeutic potential in neurodevelopmental models, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Physician

Biotechnology · Greece

WeGreened EB-2 (NIW) approved
District of Columbia 14 days 2023-02-22
The petitioner proposes to research the genetic basis and molecular pathogenesis of pediatric disorders and schizophrenia. His work focuses on identifying genetic mutations to develop novel diagnostic methods and targeted therapeutic treatments for rare genetic conditions.
View Case

Research Assistant

Biotechnology · China

WeGreened EB-2 (NIW) approved
Pennsylvania 305 days 2025-02-18
The petitioner proposes to continue research at the intersection of bioinformatics, cancer genomics, and clinical genetics to investigate rare pediatric blood cancers and type 2 diabetes. The work focuses on identifying gene mutations that drive disease mechanisms to facilitate the development of targeted therapies and improved clinical pathways.
View Case

Others

Biotechnology · Saudi Arabia

WeGreened EB-2 (NIW) approved
Kentucky 77 days 2022-05-02
The petitioner proposes to continue his research in bioengineering to improve computer-aided diagnostic tools and develop imaging alternatives for advanced diagnosis. His work focuses on drawing useful insights from patient data to enable physicians to deliver personalized treatment earlier for patients with Autism Spectrum Disorder (ASD).
View Case

Doctor

Healthcare · Israel

WeGreened EB-2 (NIW) approved
Ohio 56 days 2024-12-17
The petitioner proposes to advance the understanding of complex genetic disorders through the development of innovative genetic engineering models and tailored drug design methodologies. This work specifically focuses on investigating somatic mutations in the brains of individuals with Alzheimer’s disease to identify new pathways for diagnosis and therapeutic intervention. The endeavor aims to support the medical community in treating neurodegenerative processes and syndromic autism.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Israel

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-28.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 13 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Israel All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist